Health product recall

Oridermyl: The dosage of Triamcinolone acetonide may be out of specification for the affected lots.

Brand(s)
Last updated

Summary

Product
Oridermyl
Issue
Health products - Product safety
What to do

 

Consult your health care professional if you have any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Oridermyl

Oridermyl

DIN 02364166

Ointment

Neomycin Sulfate 3500 unit/G, Nystatin 100000 unit/G, Permethrin 10mg/g, Triamcinolone Acetonide 1mg/g

2C1103E, 2C1103G, 2C2544G

Issue

The dosage of Triamcinolone acetonide may be out of specification for the affected lots. 

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recalls: Wholesalers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies

Vetoquinol N.-A. Inc.

2000 chemin Georges,

Lavaltrie, Quebec,

J5T 3S5

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-76603

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe